The North America topical skin treatment market size was estimated at USD 6.64 billion in 2023 and is projected to grow at a CAGR of 9.60% from 2024 to 2030. The market growth can be attributed to the increasing prevalence of skin conditions, advancements in treatment options, and strate... Read More »
September 2024The China lung cancer therapeutics market size is estimated at USD 2.18 billion in 2023 and is projected to grow at a CAGR of 13.7% from 2024 to 2030. The increasing incidence of lung cancer, growing awareness and screening initiatives, and adoption of targeted therapies in the country, ... Read More »
September 2024The global pediatric diabetes therapeutic market size was estimated at USD 8.92 billion in 2023 and is projected to grow at a CAGR of 13.9% from 2024 to 2030. This growth can be attributed to a combination of rising incidence rates of diabetes among children and adolescents, advancements... Read More »
September 2024The global contraceptive drugs and devices market size was valued at USD 29.6 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market growth can be attributed to an increase in the number of sexually transmitted diseases (STDs) and unintended pregnancies.... Read More »
September 2024The Middle East & Africa parenteral nutrition market size was valued at USD 256.5 million in 2023 and is projected to grow at a CAGR of 4.4% from 2024 to 2030. The increase in the geriatric population and the growing prevalence of chronic diseases and gastrointestinal disorders are t... Read More »
September 2024The global thalassemia market size was valued at USD 850.0 million in 2023 and it is projected to grow at a CAGR of 7.8% from 2024 to 2030. This growth can be attributed to rising awareness about thalassemia and the importance of proper management, advancement in medical technology, risi... Read More »
September 2024The global primary immunodeficiency disorders market size was valued at USD 7.15 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030. The market is experiencing significant growth due to several factors. The rising incidence of PID, coupled with greater awareness... Read More »
September 2024The global NUT midline carcinoma treatment market size was estimated at USD 19.4 billion in 2023 and is projected to grow at a CAGR of 12.4% from 2024 to 2030. This growth is driven by a rising prevalence of the NUT midline carcinoma, advancements in diagnostics and therapeutics, regulat... Read More »
September 2024The global pharmerging market size was valued at USD 1.73 trillion in 2023 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This growth is attributed to the growing requirement for affordable generics. In addition, government policies that promote localization are expected t... Read More »
September 2024The global doxorubicin market size was valued at USD 989.6 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. Doxorubicin, a potent chemotherapy drug in the anthracycline class, has established a significant presence in the global pharmaceutical market. Its wid... Read More »
August 2024The global superdisintegrants market size was valued at USD 536.2 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to several factors, including the expansion of the generics market, which heavily utilizes orally disintegrating... Read More »
August 2024The global acute lymphocytic leukemia therapeutics market size was valued at USD 3.12 billion in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030. The acute lymphocytic leukemia therapeutics market is expected to grow due to the increasing rate of the condition in the yo... Read More »
August 2024The global liver disease therapeutics market size was valued at USD 19.07 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. The rise in geriatric population, changes in lifestyle, excessive consumption of alcohol, increased funding by the government in researc... Read More »
August 2024The global smoking cessation and nicotine de-addiction market size was valued at USD 25.46 billion in 2023 and is projected to grow at a CAGR of 10.4% from 2024 to 2030. The factors responsible for the market growth are the increasing prevalence of diseases caused due to smoking products... Read More »
August 2024The global bipolar disorder market size was valued at USD 4.88 billion in 2023 and is projected to grow at a CAGR of 2.7% from 2024 to 2030. The major factors responsible for the growth of this market are the rising prevalence of bipolar disorder and the increase in government investment... Read More »
August 2024The global non-small cell lung cancer therapeutics market size was valued at USD 19.10 billion in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030. The market growth is attributed to the increasing rate of patients being diagnosed with lungs disorders. Increased consump... Read More »
August 2024The global pediatric vaccines market size was valued at USD 44.87 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. This is due to increased awareness of the benefits of vaccines worldwide, resulting in higher demand for childhood vaccines. ... Read More »
August 2024The global type 2 diabetes mellitus treatment market size was estimated at USD 57.47 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2030. The growth for Type 2 diabetes mellitus (T2DM) treatment market is driven by the rising prevalence of diabetes, increasing he... Read More »
August 2024The global catastrophic antiphospholipid syndrome market size was estimated at USD 4.41 billion in 2023 and is projected to grow at a CAGR of 10.7% from 2024 to 2030. The market is driven by several key factors, including the increasing prevalence of autoimmune diseases, advancements in ... Read More »
August 2024The global blastic plasmacytoid dendritic cell neoplasm market size was estimated at USD 127.65 million in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030. The market is driven by several critical factors, including increasing incidence rates of BPDCN, advancements in t... Read More »
August 2024